nVerses Capital’s Prothena PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13,246
Closed -$130K – 183
2026
Q2
$130K Buy
+13,246
New +$131K 0.2% 228

Other funds holding PRTA

nVerses Capital's PRTA Position: Q3 2026 in Review

nVerses Capital sold out of Prothena (PRTA) in Q3 2026, closing a stake of 13,246 shares — an estimated $130K sold.

nVerses Capital first reported a position in PRTA in Q2 2026 and held it in 1 quarter. The position peaked at $130K in Q2 2026. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • nVerses Capital reported no remaining Prothena position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 13,246 Prothena shares in Q3 2026, an estimated $130K.
  • nVerses Capital first reported a position in Prothena in Q2 2026 and held it in 1 quarter.
  • nVerses Capital's Prothena position peaked at $130K in Q2 2026.
  • 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.